Search

Search Constraints

You searched for: Author/Creator Capdevila, J.

Search Results

1. OC-0337 Quality of life, functional outcome and late toxicity in patients treated within the RAPIDO trial. (August 2021)

2. 2370 Relative risk analysis of safety profile of lanreotide autogel/depot vs. placebo in patients with pancreatic and intestinal neuroendocrine tumours. (September 2015)

4. 2374 Multivariate analysis of progression-free survival in the CLARINET study of lanreotide Autogel/Depot vs placebo identifies prognostic factors in neuroendocrine tumours. (September 2015)

5. 2331 Prognostic value of neutrophil/lymphocyte ratio in intestinal and pancreatic neuroendocrine tumors: exploratory analysis of data from the CLARINET trial of lanreotide depot/autogel. (September 2015)

6. 2399 Impact of KRAS mutations on clinical outcomes in advanced refractory pancreatic cancer patients. (September 2015)

7. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Issue 1 (January 2021)

8. Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort. Issue 3 (March 2021)